BIOMAT Database Logo BIOMAT Database Logo

High dosage haloperidol therapy in chronic schizophrenic patients: a double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin. 1980

N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
February 2005, Psychopharmacology,
N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
Cyproheptadine augmentation of haloperidol in chronic schizophrenic patients: a double-blind placebo-controlled study.
June 1995, International clinical psychopharmacology,
N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
January 1981, Acta psychiatrica Scandinavica. Supplementum,
N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
Serum haloperidol levels and clinical response in chronic, treatment-resistant schizophrenic patients.
January 1988, Journal of psychopharmacology (Oxford, England),
N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
Haloperidol in acute schizophrenic inpatients. A double-blind comparison of two dosage regimens.
July 1983, Pharmacopsychiatria,
N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
January 1990, Psychopharmacology,
N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients.
August 2001, Psychoneuroendocrinology,
N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
High-dosage neuroleptic therapy for acute schizophrenic patients--two double-blind studies with benperidol.
January 1985, Pharmacopsychiatry,
N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).
March 1967, Diseases of the nervous system,
N Bjørndal, and M Bjerre, and J Gerlach, and P Kristjansen, and G Magelund, and I H Oestrich, and J Waehrens
Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
May 1990, Pharmacopsychiatry,
Copied contents to your clipboard!